TABLE 2.

Clinical parameters for the two study groups^a

Parameter	Ciprofloxacin group	Ciprofloxacinvancomycin group	P
Total no. of days with AGC of <100	9.3 (1.2)	11.2 (1.6)	0.34
Total no. of days with AGC of <500	13.9 (1.6)	14.9 (1.8)	0.69
Total no. of days with AGC of <1,000	16.5 (2.1)	16.6 (1.9)	0.99
No. of RBC transfusions (units)	9.5 (1.6)	8.8 (1.6)	0.76
No. of platelet transfusions	13.3 (3.4)	10.9 (2.5)	0.58
Length of stay (days)	30.9 (2.9)	28.7 (2.2)	0.56
Total no. of febrile days	9.5 (1.5)	11.9 (1.5)	0.26
No. of days to first fever	7.4 (1.2)	6.2 (0.86)	0.38

^aAGC, absolute granulocyte count; RBC, erythrocyte. Values are means (standard errors).